Related to ATCC Negotiates Nonexclusive Worldwide Rights to iPS Academia Japan’s Stem Cell IP

• ES Cell-Specific miRNAs Enhance Induced Pluripotency
  
• iZumi Bio and Japanese Stem Cell Research Center to Collaborate
  
• Cellular Dynamics Generates iPS Cells from Human Blood Samples
  
• Scientists Create Multiple Types of WBCs from hESCs and iPSCs
  
• Induced Pluripotent Stem Cell Technology Used to Generate Hepatocytes from Skin Cells
  
• Researchers Create iPSCs from Somatic Cells without Exogenous Transcription Factors
  
• Investigators Come Up with Virus-Free Technique to Make Stem Cells Pluripotent
  
• Lonza Enters Pluripotent Stem Cell Market through Distribution Arrangement for Axiogenesis’ Cardiomyocyte Products and Assays
  
• Millipore Licenses iPS Cell-Production Method from BU
  
  
• Sigma-Aldrich to Distribute Stemgent’s Gene Delivery Products for iPS Cells
  
• Veritas to Supply International Stem Cell’s Products in Japan
  
• Silencing of Genes May Be Responsible for Murine iPSCs’ Limitations
  
• BioTime to Take Over ES Cell International for hESC Lines
  
• Gladstone and Institute for Systems Biology to Conduct Whole-Genome Sequencing in Huntington Disease
  
• iPierian Secures $22M to Bolster iPSC-Based Drug Discovery
  
• Axiogenesis Obtains License to Japanese iPSC Technology
  
• Lonza and Roslin Cells to Develop Media and Production Processes for Stem Cells
  
• UC San Diego Gets $5M for Induced Pluripotent Stem Cell Research in Type 1 Diabetes
  
• Fate and BD Join Forces to Develop Induced Pluripotent Stem Cell Tools
  
• Cellectis and the Center for iPS Cells Research and Application Join Forces